Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
about
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisAn association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation.The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice.Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells.Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin.IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis.Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis.Antigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease.Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.The IL-17A rs2275913 single nucleotide polymorphism is associated with protection to tuberculosis but related to higher disease severity in Argentina.Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea.Striking the right immunological balance prevents progression of tuberculosis.Yin and yang of interleukin-17 in host immunity to infection.Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosisThe mechanisms of IL-17A on promoting tumor metastasis.IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and γδ Cells in Tuberculosis Infection and Disease.Variability in the response of canine and human dendritic cells stimulated with Brucella canis.The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Th1 cytokines, true functional signatures for protective immunity against TB?Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis.Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection.Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.Regulatory T cells antagonize proinflammatory response of IL-17 during cutaneous tuberculosisComparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis
P2860
Q28077155-16330F64-CAD5-4855-924D-A29B858E599FQ33691367-F959B05B-9E16-45F5-8FC5-6B71F047601BQ33779015-76C4DF92-EA80-451C-A23A-25745D937829Q33836905-59577FCE-A567-4B11-9868-CB5EF344B987Q36159388-A7991A16-3283-4767-A1E9-94E41B7F2F3BQ36246312-7556DB84-31C5-4007-8704-81865A7D3585Q37014319-951B0190-A85A-47C5-B044-BB6198F3C43BQ37034912-C068E8A1-22B4-40FD-8A6B-26433A03F0B9Q37500859-92706909-64E3-469B-9E3C-C3202D0D0F2BQ37546883-AD2C4DBA-96C3-4447-BAF5-12C089E28B5FQ37591092-742186BC-6372-439D-BCEA-597CF699E304Q37633072-2216B303-F75D-43D8-84A9-CBD0B36D05F7Q37737549-BF9194EE-6E59-4A3C-877A-0BBD5E4CC8C6Q38751464-36CD2DE4-E521-472F-8DFE-ED8EF5987C94Q39116859-F46D1865-FDDA-4903-A2C4-8329A8AE9E2CQ39437320-680C53D8-FD52-4C7D-BA88-79BB1F2E2903Q39438071-4AE72BC7-16CE-4DA6-9835-DBC2290B34F6Q40781713-4AD0CF84-8C7C-48D9-85B9-4FD4A9A8BE3FQ41697005-BBCDBAF4-75A5-4F66-A335-FE344F91AFB0Q41995692-B0AFAAD3-BC6B-40CF-A1FB-2BFA11BCB921Q42700254-7E8229D1-FD62-4391-82EE-5F0E52EDDE28Q46269912-3B7C1FDE-5CA5-4756-93A4-80D20A4F1D72Q47572706-ECCC89F0-8A67-4CCC-B0D6-EF59171E9490Q47834561-814DE9E0-C03C-4B98-BFD3-17AC76260D14Q49900955-C92D51E6-EC07-447F-B8BF-55E53DBA9ABCQ50319373-84F0E7DC-B86E-47C0-8B67-FF670E176DF6Q52356828-078D5966-6505-4893-B4F6-901635CEA784Q55343159-A1F3044F-9239-4E8C-A332-4FDAAA7FF8C7Q57490353-E49538B5-92A0-4C7A-85BC-44FC8303AEF8Q58695834-F5D1BE87-3A44-4032-A4DA-141E36DE6C2C
P2860
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@ast
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@en
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@nl
type
label
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@ast
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@en
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@nl
prefLabel
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@ast
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@en
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@nl
P2860
P921
P3181
P356
P1476
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
@en
P2093
A V Panteleev
P2860
P304
P3181
P356
10.1155/2015/854507
P407
P5008
P577
2015-11-10T00:00:00Z